Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients

Carcinogenesis

Volumn 33, Issue 9, 2012, Pages 1797-1805

  Xiong, Donghai ^a   Li, Guangming ^b,c   Li, Kezhen ^d   Xu, Qinzi ^d   Pan, Zhongjie ^e   Ding, Feng ^a   Vedell, Peter ^a   Liu, Pengyuan ^a   Cui, Peng ^a   Hua, Xing ^a   Jiang, Hui ^a   Yin, Yuxin ^a   Zhu, Ze ^b   Li, Xiaomian ^b   Zhang, Bin ^b   Ma, Ding ^d   Wang, Yian ^c   You, Ming ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c WASHINGTON UNIVERSITY   (United States)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e Tianjin Union Medical Centre   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; EXOME; EXTRACELLULAR MATRIX; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MALE; MATRIX REMODELING ASSOCIATED 5 GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOMATIC MUTATION; TUMOR GENE;

ANTIGENS, NUCLEAR; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, NON-SMALL-CELL LUNG; EXOME; GENES, NEOPLASM; HUMANS; LUNG NEOPLASMS; MUTATION; PROTEOGLYCANS;

EID: 84865569656     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs210     Document Type: Article

References (37)

1. Houwen, L. (2003) State of the art: lung cancer in China. Ann. Thorac. Cardiovasc. Surg., 9, 147-148.
2. Ding, L. et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 455, 1069-1075.
3. Lee, W. et al. (2010) The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature, 465, 473-477.
4. Pleasance, E.D. et al. (2010) A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature, 463, 184-190.
5. Li, H. et al. (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics, 25, 1754-1760.
6. McKenna, A. et al. (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res., 20, 1297-1303.
7. Koboldt, D.C. et al. (2009) VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics, 25, 2283-2285.
8. Li, Y. et al. (2010) Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants. Nat. Genet., 42, 969-972.
9. Boca, S.M. et al. (2010) Patient-oriented gene set analysis for cancer mutation data. Genome Biol., 11, R112.
10. Parsons, D.W. et al. (2011) The genetic landscape of the childhood cancer medulloblastoma. Science, 331, 435-439.
11. Jones, S. et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science, 321, 1801-1806.
12. Rozek, L.S. et al. (2010) Smoking, gender, and ethnicity predict somatic BRAF mutations in colorectal cancer. Cancer Epidemiol. Biomarkers Prev., 19, 838-843.
13. Rødningen, O.K. et al. (2008) Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis. Radiother. Oncol., 86, 314-320.
14. Sugarbaker, D.J. et al. (2008) Transcriptome sequencing of malignant pleural mesothelioma tumors. Proc. Natl. Acad. Sci. U.S.A., 105, 3521-3526.
15. Buckanovich, R.J. et al. (2007) Tumor vascular proteins as biomarkers in ovarian cancer. J. Clin. Oncol., 25, 852-861.
16. Zhang, C. et al. (2009) Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma. Clin. Cancer Res., 15, 4017-4027.
17. de Wit, J. et al. (2011) Role of leucine-rich repeat proteins in the development and function of neural circuits. Annu. Rev. Cell Dev. Biol., 27, 697-729.
18. Yu, J. et al. (2008) Tumor-derived extracellular mutations of PTPRT/PTPrho are defective in cell adhesion. Mol. Cancer Res., 6, 1106-1113.
19. Gao, Y. et al. (2010) LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proc. Natl. Acad. Sci. U.S.A., 107, 18892-18897.
20. Ahmed, J. et al. (2011) CancerResource: a comprehensive database of cancer-relevant proteins and compound interactions supported by experimental knowledge. Nucleic Acids Res., 39, D960-D967.
21. Bozic, I. et al. (2010) Accumulation of driver and passenger mutations during tumor progression. Proc. Natl. Acad. Sci. U.S.A., 107, 18545-18550.
22. Horii, Y. et al. (2006) The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells. Oncol. Rep., 15, 1191-1195.
23. Kim, K.N. et al. (2006) Retinoic acid and ascorbic acid act synergistically in inhibiting human breast cancer cell proliferation. J. Nutr. Biochem., 17, 454-462.
24. Hazlehurst, L.A. et al. (2001) Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells. Blood, 98, 1897-1903.
25. Pupa, S.M. et al. (2007) Regulation of breast cancer response to chemotherapy by fibulin-1. Cancer Res., 67, 4271-4277.
26. Han, S. et al. (2006) Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/ S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Cancer Res., 66, 315-323.
27. Kazemi, T. et al. (2008) Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia. Int. J. Cancer, 123, 2113-2119.
28. Kazemi, T. et al. (2009) Low representation of Fc receptor-like 1-5 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia. Cancer Immunol. Immunother., 58, 989-996.
29. Ali, A.H. et al. (2011) Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure. Mol. Carcinog., 50, 89-99.
30. Zhang, Y. et al. (2011) Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer. Cancer Lett., 303, 21-28.
31. Burgess, D.J. (2011) Aneuploidy stokes the fire. Nat. Rev. Genet., 12, 666.
32. Kolodner, R.D. et al. (2011) Cancer. Aneuploidy drives a mutator phenotype in cancer. Science, 333, 942-943.
33. Sheltzer, J.M. et al. (2011) Aneuploidy drives genomic instability in yeast. Science, 333, 1026-1030.
34. Solomon, D.A. et al. (2011) Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science, 333, 1039-1043.
35. Jung, Y. et al. (2012) Discovery of ALK-PTPN3 gene fusion from human non-small cell lung carcinoma cell line using next generation RNA sequencing. Genes. Chromosomes Cancer, 51, 590-597.
36. Lopez, J.I. et al. (2008) Biomechanical regulation of cell orientation and fate. Oncogene, 27, 6981-6993.
37. Streuli, C. (1999) Extracellular matrix remodelling and cellular differentiation. Curr. Opin. Cell Biol., 11, 634-640.